Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057820 · ClinicalTrials.gov registry record · NA
Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach
A NA study, sponsored by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program.
- Completed
- Registry status
- NA
- Development phase
- 1,305
- Enrollment target
NCT04057820 is a NA study that has completed, run by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program. The registered enrollment target is 1,305 participants.
The verdict
NCT04057820, a NA study, has completed, sponsored by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,305 participants
- Enrollment target
Study Summary
The overall objective is to determine if the ESC care approach will reduce the time until infants being managed for NOWS are medically ready for discharge.
Interventions
- OTHER Finnegan Neonatal Abstinence Scoring Tool
- OTHER Eat, Sleep, Console (ESC) care tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,305 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2024-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057820
The ClinicalTrials.gov registry entry for NCT04057820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Finnegan Neonatal Abstinence Scoring Tool is the first listed.
NCT04057820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04057820 about?
NCT04057820 is a clinical study titled "Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach". The overall objective is to determine if the ESC care approach will reduce the time until infants being managed for NOWS are medically ready for discharge.
What is the current status of trial NCT04057820?
This trial is currently completed. It is a NA study. The enrollment target is 1,305 participants. The study started on 2020-09-08. Estimated completion is 2024-09-24.
What interventions are being tested in trial NCT04057820?
The interventions under investigation include: Finnegan Neonatal Abstinence Scoring Tool (OTHER), Eat, Sleep, Console (ESC) care tool (OTHER).
Who is sponsoring clinical trial NCT04057820?
This trial is sponsored by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.